Sunovion Announces Acceptance by the US FDA of the New Drug Application for Dasotraline for the Treatment of Adults with Moderate-to-Severe Binge Eating Disorder - Yahoo Finance

Submitted by Anonymous (not verified) on Tue, 07/30/2019 - 12:00

Sunovion Announces Acceptance by the US FDA of the New Drug Application for Dasotraline for the Treatment of Adults with Moderate-to-Severe Binge Eating Disorder  Yahoo FinanceBinge eating disorder is estimated to affect 4.1 million Americans and may occur at a rate that is three times higher than anorexia and bulimia combined1-